On July 29th, the South African Medical Research Council (SAMRC) launched the African Genomics Centre in Cape Town with the support of MGI, becoming the first high-throughput genome sequencing center in Africa. The MGI genetic sequencer MGISEQ-2000 has been installed in the laboratory and assembled and tested. It will provide solid instrument support for a state-of-the art research facility that will refine the science of genomics for personalized medicine to benefit Africa's diverse gene pool. ...

TOKYO, May 25, 2019 – MGI, a subsidiary of global genomics leader BGI Group, attended the European Molecular Biology Organization (EMBO) Workshop on Single Cell Biology in Tokyo, and hosted a luncheon session on May 21st, 2019. Dr. Sarah Teichmann from the Wellcome Sanger Institute presented her work on single cell sequencing, and Dr. Kedar Natarajan shared his experience on MGI sequencing platforms. Dr. Teichmann shared her systematic evaluation workflow for different protocols, platforms and...

TOKYO, May 21, 2019 – MGI, a subsidiary of global genomics leader BGI Group, announced it will begin marketing a total package for single cell RNA Sequencing as part of the 10x Genomics' Compatible Product Partner Program on MGI's MGISEQ and BGISEQ sequencing platform. The total package includes the new MGIEasy Universal Library Conversion Kit and 10x Genomics Chromium Controller and Single Cell RNA Packages, which are compatible with the MGISEQ and BGISEQ platform. MGI presented the package a...

SHENZHEN, May 7, 2019 – MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, and Genoks, a Turkish company committed to providing genetic sequencing platforms and kits in Turkey, today jointly announced that they have entered an exclusive collaborative agreement on Whole Exome Sequencing tests, which will be performed on the MGISEQ-2000 platform in Genoks Genetic Disease Diagnostic Center. Under the partnership, Genoks will offer its regional knowledge and distribution network, and MGI will pr...

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's early access program for its newest ultra-high-throughput , , during a presentation at China Focus@JPM Week on the eve of the 37th annual J.P. Morgan Healthcare Conference. clinical diagnostic applications The MGISEQ-T7 vastly improves speed, th...

--Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution-- MGIUnder the terms of the agreement, MGI will distribute CleanPlex Custom and Ready-to-Use NGS Panels for MGI's MGISEQ and BGISEQ sequencing platforms, including MGI's new ultra-high throughput , and on future sequencing platforms from MGI/BGI. CleanPlex MGI NGS panels will be available for oncology, reproductive he...